Ingrid Anfray is currently Carenity's Business Developer. Her role involves developing Carenity's activities with new clients and accompanying existing health care industry clients (pharmaceutical libraries, medical device manufacturers, biotech, etc.) in new observational/RWE projects from the conception phase, through results and submission to scientific publications.
After earning an MBA at ESG Paris, Ingrid Anfray has worked for over 15 years in the pharmaceutical sector, principally in Sales. She is also the founder of two start ups that commercialized an innovative medical diagnosis system based on oxidant stress in Switzerland and France, then acted as a sales executive on behalf of an evolving start-up in the pharmaceutical industry. She joined Carenity in 2019 after acting as a innovation strategy consultant for several start-ups that specialized in health/e-health.
Created: 1/27/20 - Updated: 1/27/20